While there are US Food and Drug Administration (FDA) approved tests for EGFR mutations (cobas EGFR Mutation Test v2), NGS allows the ability to analyze multiple genes at the same time or the entire cancer genome [41]. The gene discussed is EGFR; the disease is cancer.